1 Human Insulin Delivery System Market Overview 1.1 Product Overview and Scope of Human Insulin Delivery System 1.2 Human Insulin Delivery System Segment by Type 1.2.1 Global Human Insulin Delivery System Market Value Comparison by Type (2023-2029) 1.2.2 Automatic 1.2.3 Manual 1.3 Human Insulin Delivery System Segment by Application 1.3.1 Global Human Insulin Delivery System Market Value by Application: (2023-2029) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Homecare 1.4 Global Human Insulin Delivery System Market Size Estimates and Forecasts 1.4.1 Global Human Insulin Delivery System Revenue 2018-2029 1.4.2 Global Human Insulin Delivery System Sales 2018-2029 1.4.3 Global Human Insulin Delivery System Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Human Insulin Delivery System Market Competition by Manufacturers 2.1 Global Human Insulin Delivery System Sales Market Share by Manufacturers (2018-2023) 2.2 Global Human Insulin Delivery System Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Human Insulin Delivery System Average Price by Manufacturers (2018-2023) 2.4 Global Human Insulin Delivery System Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Human Insulin Delivery System, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Human Insulin Delivery System, Product Type & Application 2.7 Human Insulin Delivery System Market Competitive Situation and Trends 2.7.1 Human Insulin Delivery System Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Human Insulin Delivery System Players Market Share by Revenue 2.7.3 Global Human Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Human Insulin Delivery System Retrospective Market Scenario by Region 3.1 Global Human Insulin Delivery System Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Human Insulin Delivery System Global Human Insulin Delivery System Sales by Region: 2018-2029 3.2.1 Global Human Insulin Delivery System Sales by Region: 2018-2023 3.2.2 Global Human Insulin Delivery System Sales by Region: 2024-2029 3.3 Global Human Insulin Delivery System Global Human Insulin Delivery System Revenue by Region: 2018-2029 3.3.1 Global Human Insulin Delivery System Revenue by Region: 2018-2023 3.3.2 Global Human Insulin Delivery System Revenue by Region: 2024-2029 3.4 North America Human Insulin Delivery System Market Facts & Figures by Country 3.4.1 North America Human Insulin Delivery System Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Human Insulin Delivery System Sales by Country (2018-2029) 3.4.3 North America Human Insulin Delivery System Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Human Insulin Delivery System Market Facts & Figures by Country 3.5.1 Europe Human Insulin Delivery System Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Human Insulin Delivery System Sales by Country (2018-2029) 3.5.3 Europe Human Insulin Delivery System Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Human Insulin Delivery System Market Facts & Figures by Country 3.6.1 Asia Pacific Human Insulin Delivery System Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Human Insulin Delivery System Sales by Country (2018-2029) 3.6.3 Asia Pacific Human Insulin Delivery System Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America Human Insulin Delivery System Market Facts & Figures by Country 3.7.1 Latin America Human Insulin Delivery System Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Human Insulin Delivery System Sales by Country (2018-2029) 3.7.3 Latin America Human Insulin Delivery System Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Human Insulin Delivery System Market Facts & Figures by Country 3.8.1 Middle East and Africa Human Insulin Delivery System Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Human Insulin Delivery System Sales by Country (2018-2029) 3.8.3 Middle East and Africa Human Insulin Delivery System Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 UAE 4 Segment by Type 4.1 Global Human Insulin Delivery System Sales by Type (2018-2029) 4.1.1 Global Human Insulin Delivery System Sales by Type (2018-2023) 4.1.2 Global Human Insulin Delivery System Sales by Type (2024-2029) 4.1.3 Global Human Insulin Delivery System Sales Market Share by Type (2018-2029) 4.2 Global Human Insulin Delivery System Revenue by Type (2018-2029) 4.2.1 Global Human Insulin Delivery System Revenue by Type (2018-2023) 4.2.2 Global Human Insulin Delivery System Revenue by Type (2024-2029) 4.2.3 Global Human Insulin Delivery System Revenue Market Share by Type (2018-2029) 4.3 Global Human Insulin Delivery System Price by Type (2018-2029) 5 Segment by Application 5.1 Global Human Insulin Delivery System Sales by Application (2018-2029) 5.1.1 Global Human Insulin Delivery System Sales by Application (2018-2023) 5.1.2 Global Human Insulin Delivery System Sales by Application (2024-2029) 5.1.3 Global Human Insulin Delivery System Sales Market Share by Application (2018-2029) 5.2 Global Human Insulin Delivery System Revenue by Application (2018-2029) 5.2.1 Global Human Insulin Delivery System Revenue by Application (2018-2023) 5.2.2 Global Human Insulin Delivery System Revenue by Application (2024-2029) 5.2.3 Global Human Insulin Delivery System Revenue Market Share by Application (2018-2029) 5.3 Global Human Insulin Delivery System Price by Application (2018-2029) 6 Key Companies Profiled 6.1 BD 6.1.1 BD Corporation Information 6.1.2 BD Description and Business Overview 6.1.3 BD Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.1.4 BD Human Insulin Delivery System Product Portfolio 6.1.5 BD Recent Developments/Updates 6.2 Novo Nordisk 6.2.1 Novo Nordisk Corporation Information 6.2.2 Novo Nordisk Description and Business Overview 6.2.3 Novo Nordisk Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Novo Nordisk Human Insulin Delivery System Product Portfolio 6.2.5 Novo Nordisk Recent Developments/Updates 6.3 Medtronic 6.3.1 Medtronic Corporation Information 6.3.2 Medtronic Description and Business Overview 6.3.3 Medtronic Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Medtronic Human Insulin Delivery System Product Portfolio 6.3.5 Medtronic Recent Developments/Updates 6.4 Sanofi 6.4.1 Sanofi Corporation Information 6.4.2 Sanofi Description and Business Overview 6.4.3 Sanofi Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Sanofi Human Insulin Delivery System Product Portfolio 6.4.5 Sanofi Recent Developments/Updates 6.5 ELI Lilly and Company 6.5.1 ELI Lilly and Company Corporation Information 6.5.2 ELI Lilly and Company Description and Business Overview 6.5.3 ELI Lilly and Company Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.5.4 ELI Lilly and Company Human Insulin Delivery System Product Portfolio 6.5.5 ELI Lilly and Company Recent Developments/Updates 6.6 Ypsomed Holding 6.6.1 Ypsomed Holding Corporation Information 6.6.2 Ypsomed Holding Description and Business Overview 6.6.3 Ypsomed Holding Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Ypsomed Holding Human Insulin Delivery System Product Portfolio 6.6.5 Ypsomed Holding Recent Developments/Updates 6.7 Animas Corporation 6.6.1 Animas Corporation Corporation Information 6.6.2 Animas Corporation Description and Business Overview 6.6.3 Animas Corporation Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Animas Corporation Human Insulin Delivery System Product Portfolio 6.7.5 Animas Corporation Recent Developments/Updates 6.8 Tandem Diabetes Care 6.8.1 Tandem Diabetes Care Corporation Information 6.8.2 Tandem Diabetes Care Description and Business Overview 6.8.3 Tandem Diabetes Care Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.8.4 Tandem Diabetes Care Human Insulin Delivery System Product Portfolio 6.8.5 Tandem Diabetes Care Recent Developments/Updates 6.9 Insulet Corporation 6.9.1 Insulet Corporation Corporation Information 6.9.2 Insulet Corporation Description and Business Overview 6.9.3 Insulet Corporation Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.9.4 Insulet Corporation Human Insulin Delivery System Product Portfolio 6.9.5 Insulet Corporation Recent Developments/Updates 6.10 Biocon 6.10.1 Biocon Corporation Information 6.10.2 Biocon Description and Business Overview 6.10.3 Biocon Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.10.4 Biocon Human Insulin Delivery System Product Portfolio 6.10.5 Biocon Recent Developments/Updates 6.11 Roche 6.11.1 Roche Corporation Information 6.11.2 Roche Human Insulin Delivery System Description and Business Overview 6.11.3 Roche Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.11.4 Roche Human Insulin Delivery System Product Portfolio 6.11.5 Roche Recent Developments/Updates 6.12 Johnson & Johnson 6.12.1 Johnson & Johnson Corporation Information 6.12.2 Johnson & Johnson Human Insulin Delivery System Description and Business Overview 6.12.3 Johnson & Johnson Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.12.4 Johnson & Johnson Human Insulin Delivery System Product Portfolio 6.12.5 Johnson & Johnson Recent Developments/Updates 6.13 Microport 6.13.1 Microport Corporation Information 6.13.2 Microport Human Insulin Delivery System Description and Business Overview 6.13.3 Microport Human Insulin Delivery System Sales, Revenue and Gross Margin (2018-2023) 6.13.4 Microport Human Insulin Delivery System Product Portfolio 6.13.5 Microport Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Human Insulin Delivery System Industry Chain Analysis 7.2 Human Insulin Delivery System Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Human Insulin Delivery System Production Mode & Process 7.4 Human Insulin Delivery System Sales and Marketing 7.4.1 Human Insulin Delivery System Sales Channels 7.4.2 Human Insulin Delivery System Distributors 7.5 Human Insulin Delivery System Customers 8 Human Insulin Delivery System Market Dynamics 8.1 Human Insulin Delivery System Industry Trends 8.2 Human Insulin Delivery System Market Drivers 8.3 Human Insulin Delivery System Market Challenges 8.4 Human Insulin Delivery System Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Human Insulin Delivery System Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Human Insulin Delivery System Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Human Insulin Delivery System Market Competitive Situation by Manufacturers in 2022 Table 4. Global Human Insulin Delivery System Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global Human Insulin Delivery System Sales Market Share by Manufacturers (2018-2023) Table 6. Global Human Insulin Delivery System Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Human Insulin Delivery System Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Human Insulin Delivery System Average Price (US$/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Human Insulin Delivery System, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Human Insulin Delivery System, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Human Insulin Delivery System, Product Type & Application Table 12. Global Key Manufacturers of Human Insulin Delivery System, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Human Insulin Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Delivery System as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Human Insulin Delivery System Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Human Insulin Delivery System Sales by Region (2018-2023) & (K Units) Table 18. Global Human Insulin Delivery System Sales Market Share by Region (2018-2023) Table 19. Global Human Insulin Delivery System Sales by Region (2024-2029) & (K Units) Table 20. Global Human Insulin Delivery System Sales Market Share by Region (2024-2029) Table 21. Global Human Insulin Delivery System Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Human Insulin Delivery System Revenue Market Share by Region (2018-2023) Table 23. Global Human Insulin Delivery System Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Human Insulin Delivery System Revenue Market Share by Region (2024-2029) Table 25. North America Human Insulin Delivery System Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Human Insulin Delivery System Sales by Country (2018-2023) & (K Units) Table 27. North America Human Insulin Delivery System Sales by Country (2024-2029) & (K Units) Table 28. North America Human Insulin Delivery System Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Human Insulin Delivery System Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Human Insulin Delivery System Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Human Insulin Delivery System Sales by Country (2018-2023) & (K Units) Table 32. Europe Human Insulin Delivery System Sales by Country (2024-2029) & (K Units) Table 33. Europe Human Insulin Delivery System Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Human Insulin Delivery System Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Human Insulin Delivery System Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Human Insulin Delivery System Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific Human Insulin Delivery System Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific Human Insulin Delivery System Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Human Insulin Delivery System Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Human Insulin Delivery System Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Human Insulin Delivery System Sales by Country (2018-2023) & (K Units) Table 42. Latin America Human Insulin Delivery System Sales by Country (2024-2029) & (K Units) Table 43. Latin America Human Insulin Delivery System Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Human Insulin Delivery System Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Human Insulin Delivery System Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Human Insulin Delivery System Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa Human Insulin Delivery System Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa Human Insulin Delivery System Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Human Insulin Delivery System Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Human Insulin Delivery System Sales (K Units) by Type (2018-2023) Table 51. Global Human Insulin Delivery System Sales (K Units) by Type (2024-2029) Table 52. Global Human Insulin Delivery System Sales Market Share by Type (2018-2023) Table 53. Global Human Insulin Delivery System Sales Market Share by Type (2024-2029) Table 54. Global Human Insulin Delivery System Revenue (US$ Million) by Type (2018-2023) Table 55. Global Human Insulin Delivery System Revenue (US$ Million) by Type (2024-2029) Table 56. Global Human Insulin Delivery System Revenue Market Share by Type (2018-2023) Table 57. Global Human Insulin Delivery System Revenue Market Share by Type (2024-2029) Table 58. Global Human Insulin Delivery System Price (US$/Unit) by Type (2018-2023) Table 59. Global Human Insulin Delivery System Price (US$/Unit) by Type (2024-2029) Table 60. Global Human Insulin Delivery System Sales (K Units) by Application (2018-2023) Table 61. Global Human Insulin Delivery System Sales (K Units) by Application (2024-2029) Table 62. Global Human Insulin Delivery System Sales Market Share by Application (2018-2023) Table 63. Global Human Insulin Delivery System Sales Market Share by Application (2024-2029) Table 64. Global Human Insulin Delivery System Revenue (US$ Million) by Application (2018-2023) Table 65. Global Human Insulin Delivery System Revenue (US$ Million) by Application (2024-2029) Table 66. Global Human Insulin Delivery System Revenue Market Share by Application (2018-2023) Table 67. Global Human Insulin Delivery System Revenue Market Share by Application (2024-2029) Table 68. Global Human Insulin Delivery System Price (US$/Unit) by Application (2018-2023) Table 69. Global Human Insulin Delivery System Price (US$/Unit) by Application (2024-2029) Table 70. BD Corporation Information Table 71. BD Description and Business Overview Table 72. BD Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 73. BD Human Insulin Delivery System Product Table 74. BD Recent Developments/Updates Table 75. Novo Nordisk Corporation Information Table 76. Novo Nordisk Description and Business Overview Table 77. Novo Nordisk Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 78. Novo Nordisk Human Insulin Delivery System Product Table 79. Novo Nordisk Recent Developments/Updates Table 80. Medtronic Corporation Information Table 81. Medtronic Description and Business Overview Table 82. Medtronic Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Medtronic Human Insulin Delivery System Product Table 84. Medtronic Recent Developments/Updates Table 85. Sanofi Corporation Information Table 86. Sanofi Description and Business Overview Table 87. Sanofi Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. Sanofi Human Insulin Delivery System Product Table 89. Sanofi Recent Developments/Updates Table 90. ELI Lilly and Company Corporation Information Table 91. ELI Lilly and Company Description and Business Overview Table 92. ELI Lilly and Company Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. ELI Lilly and Company Human Insulin Delivery System Product Table 94. ELI Lilly and Company Recent Developments/Updates Table 95. Ypsomed Holding Corporation Information Table 96. Ypsomed Holding Description and Business Overview Table 97. Ypsomed Holding Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. Ypsomed Holding Human Insulin Delivery System Product Table 99. Ypsomed Holding Recent Developments/Updates Table 100. Animas Corporation Corporation Information Table 101. Animas Corporation Description and Business Overview Table 102. Animas Corporation Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. Animas Corporation Human Insulin Delivery System Product Table 104. Animas Corporation Recent Developments/Updates Table 105. Tandem Diabetes Care Corporation Information Table 106. Tandem Diabetes Care Description and Business Overview Table 107. Tandem Diabetes Care Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. Tandem Diabetes Care Human Insulin Delivery System Product Table 109. Tandem Diabetes Care Recent Developments/Updates Table 110. Insulet Corporation Corporation Information Table 111. Insulet Corporation Description and Business Overview Table 112. Insulet Corporation Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. Insulet Corporation Human Insulin Delivery System Product Table 114. Insulet Corporation Recent Developments/Updates Table 115. Biocon Corporation Information Table 116. Biocon Description and Business Overview Table 117. Biocon Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. Biocon Human Insulin Delivery System Product Table 119. Biocon Recent Developments/Updates Table 120. Roche Corporation Information Table 121. Roche Description and Business Overview Table 122. Roche Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 123. Roche Human Insulin Delivery System Product Table 124. Roche Recent Developments/Updates Table 125. Johnson & Johnson Corporation Information Table 126. Johnson & Johnson Description and Business Overview Table 127. Johnson & Johnson Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 128. Johnson & Johnson Human Insulin Delivery System Product Table 129. Johnson & Johnson Recent Developments/Updates Table 130. Microport Corporation Information Table 131. Microport Description and Business Overview Table 132. Microport Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 133. Microport Human Insulin Delivery System Product Table 134. Microport Recent Developments/Updates Table 135. Key Raw Materials Lists Table 136. Raw Materials Key Suppliers Lists Table 137. Human Insulin Delivery System Distributors List Table 138. Human Insulin Delivery System Customers List Table 139. Human Insulin Delivery System Market Trends Table 140. Human Insulin Delivery System Market Drivers Table 141. Human Insulin Delivery System Market Challenges Table 142. Human Insulin Delivery System Market Restraints Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Human Insulin Delivery System Figure 2. Global Human Insulin Delivery System Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Human Insulin Delivery System Market Share by Type in 2022 & 2029 Figure 4. Automatic Product Picture Figure 5. Manual Product Picture Figure 6. Global Human Insulin Delivery System Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Human Insulin Delivery System Market Share by Application in 2022 & 2029 Figure 8. Hospitals Figure 9. Clinics Figure 10. Homecare Figure 11. Global Human Insulin Delivery System Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 12. Global Human Insulin Delivery System Market Size (2018-2029) & (US$ Million) Figure 13. Global Human Insulin Delivery System Sales (2018-2029) & (K Units) Figure 14. Global Human Insulin Delivery System Average Price (US$/Unit) & (2018-2029) Figure 15. Human Insulin Delivery System Report Years Considered Figure 16. Human Insulin Delivery System Sales Share by Manufacturers in 2022 Figure 17. Global Human Insulin Delivery System Revenue Share by Manufacturers in 2022 Figure 18. The Global 5 and 10 Largest Human Insulin Delivery System Players: Market Share by Revenue in 2022 Figure 19. Human Insulin Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 20. Global Human Insulin Delivery System Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 21. North America Human Insulin Delivery System Sales Market Share by Country (2018-2029) Figure 22. North America Human Insulin Delivery System Revenue Market Share by Country (2018-2029) Figure 23. U.S. Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 24. Canada Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 25. Europe Human Insulin Delivery System Sales Market Share by Country (2018-2029) Figure 26. Europe Human Insulin Delivery System Revenue Market Share by Country (2018-2029) Figure 27. Germany Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. France Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. U.K. Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. Italy Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. Russia Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. Asia Pacific Human Insulin Delivery System Sales Market Share by Region (2018-2029) Figure 33. Asia Pacific Human Insulin Delivery System Revenue Market Share by Region (2018-2029) Figure 34. China Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Japan Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. South Korea Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. India Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Australia Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Taiwan Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Indonesia Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Thailand Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Malaysia Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Philippines Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Latin America Human Insulin Delivery System Sales Market Share by Country (2018-2029) Figure 45. Latin America Human Insulin Delivery System Revenue Market Share by Country (2018-2029) Figure 46. Mexico Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Brazil Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Argentina Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Middle East & Africa Human Insulin Delivery System Sales Market Share by Country (2018-2029) Figure 50. Middle East & Africa Human Insulin Delivery System Revenue Market Share by Country (2018-2029) Figure 51. Turkey Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. Saudi Arabia Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. UAE Human Insulin Delivery System Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. Global Sales Market Share of Human Insulin Delivery System by Type (2018-2029) Figure 55. Global Revenue Market Share of Human Insulin Delivery System by Type (2018-2029) Figure 56. Global Human Insulin Delivery System Price (US$/Unit) by Type (2018-2029) Figure 57. Global Sales Market Share of Human Insulin Delivery System by Application (2018-2029) Figure 58. Global Revenue Market Share of Human Insulin Delivery System by Application (2018-2029) Figure 59. Global Human Insulin Delivery System Price (US$/Unit) by Application (2018-2029) Figure 60. Human Insulin Delivery System Value Chain Figure 61. Human Insulin Delivery System Production Process Figure 62. Channels of Distribution (Direct Vs Distribution) Figure 63. Distributors Profiles Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

BD Novo Nordisk Medtronic Sanofi ELI Lilly and Company Ypsomed Holding Animas Corporation Tandem Diabetes Care Insulet Corporation Biocon Roche Johnson & Johnson Microport